Technology is quickly changing the retail experience. To stay ahead of the curve, Lowe's created its Innovation Labs, to help customers and employees solve problems in their day to day.
Kyle Nel, founder and executive director of Lowe's Innovation Labs, gave Cheddar an inside look at the new technology the company is working on. He says AR and VR are its main focus right now.
The company is testing out its Holoroom, a virtual reality design and visualization tool that allows homeowners to have an immersive home improvement experience, at few locations around the country.
Nel says that hiring science fiction writers to sit around and envision fantastical futures, is at the core of Lowe's innovation strategy. The writers are complemented by a second team that actually make those ideas a reality, he said.
Mortgage rates have dropped below 7% for the first time since the middle of August.
Taylor Swift grossed nearly $2 billion this year, according to Billboard.
A study from US News and World Report has found the most affordable place to retire is in Ohio.
Millions of households could see higher internet costs next year as the affordable connectivity program could end.
Viveca Chow, NYC lifestyle expert, spoke with Cheddar News to provide tips on how to have some festive fun in the city on a budget.
Apple announced that it's releasing an iPhone security update to prevent attackers from acquiring users' private passcodes.
As the new year approaches, many people are looking to find a job with a higher salary or are planning to ask their current boss for a raise. Taliya Bashani, real estate attorney and negotiation expert, joined Cheddar News to provide tips on how to properly and better negotiate better financial terms.
Meta says it will start testing a program that would allow posts from Threads to appear on other social media sites.
Several healthcare companies are reportedly joining President Biden's artificial intelligence risk management plan.
The Biden administration says it will impose inflation penalties on dozens of drug makers to lower costs for those on Medicare.
